Gastroenterology
Volume 129, Issue 5 , Pages 1392-1399, November 2005

MLH1 Germline Epimutations as a Factor in Hereditary Nonpolyposis Colorectal Cancer

  • Megan Hitchins

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
    • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
  • ,
  • Rachel Williams

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • ,
  • Kayfong Cheong

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • ,
  • Nimita Halani

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • ,
  • Vita A.P. Lin

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • ,
  • Deborah Packham

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
    • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
  • ,
  • Sue Ku

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • ,
  • Andrew Buckle

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • ,
  • Nicholas Hawkins

      Affiliations

    • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
  • ,
  • John Burn

      Affiliations

    • Institute of Human Genetics, University of Newcastle upon Tyne, Newcastle, England
  • ,
  • Steven Gallinger

      Affiliations

    • Mount Sinai Hospital, Toronto, Ontario, Canada
  • ,
  • Jack Goldblatt

      Affiliations

    • Genetic Services of Western Australia, School of Paediatrics and Child Health, King Edward Memorial Hospital, University of Western Australia, Subiaco, Perth, Western Australia, Australia
  • ,
  • Judy Kirk

      Affiliations

    • Familial Cancer Service, Westmead Hospital, Westmead, New South Wales, Australia
  • ,
  • Ian Tomlinson

      Affiliations

    • Cancer Research UK, London Institute, London, England
  • ,
  • Rodney Scott

      Affiliations

    • University of Newcastle and the Hunter Medical Research Institute, Newcastle, New South Wales, Australia
  • ,
  • Allan Spigelman

      Affiliations

    • University of Newcastle and the Hunter Medical Research Institute, Newcastle, New South Wales, Australia
  • ,
  • Catherine Suter

      Affiliations

    • Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia
  • ,
  • David Martin

      Affiliations

    • Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia
  • ,
  • Graeme Suthers

      Affiliations

    • Familial Cancer Unit, Department of Genetic Medicine, Women’s and Children’s Hospital, North Adelaide, South Australia, Australia
  • ,
  • Robyn Ward

      Affiliations

    • Department of Medical Oncology, St Vincent’s Hospital, Sydney, New South Wales, Australia
    • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
    • Corresponding Author InformationAddress requests for reprints to: Robyn Ward, MD, PhD, Department of Medical Oncology, St Vincent’s Hospital, Victoria Street, Darlinghurst, New South Wales, 2010, Australia. fax: (61) 283823386.

Received 12 April 2005; accepted 14 July 2005. published online 14 September 2005.

Background & Aims: Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by heterozygous germline sequence mutations of DNA mismatch repair genes, most frequently MLH1 or MSH2. A novel molecular mechanism for HNPCC has recently been suggested by the finding of individuals with soma-wide monoallelic hypermethylation of the MLH1 gene promoter. In this study, we determined the frequency and role of germline epimutations of MLH1 in HNPCC. Methods: A cohort of 160 probands from HNPCC families who did not harbor germline sequence mutations in the mismatch repair genes were screened for methylation of the MLH1 and EPM2AIP1 promoters by combined bisulfite and restriction analyses. Allelic expression and family transmission of MLH1 were determined using polymorphisms in intron 4 and the 3′ untranslated region. Results: One of 160 individuals had monoallelic MLH1 hypermethylation in peripheral blood, hair follicles, and buccal mucosa, indicative of a soma-wide alteration. Monoallelic transcription of the paternal MLH1 allele was shown using a heterozygous expressed polymorphism within the 3′ untranslated region. The hypermethylated allele was maternally transmitted, however, the mother and siblings who inherited the same maternal homologue were unmethylated at MLH1, suggesting the epimutation arose as a de novo event. Conclusions: Germline MLH1 epimutations are functionally equivalent to an inactivating mutation and produce a clinical phenotype that resembles HNPCC. Inheritance of epimutations is weak, so family history is not a useful guide for screening. Germline epimutations should be suspected in younger individuals without a family history who present with a microsatellite unstable tumor showing loss of MLH1 expression.

Abbreviations used in this paper:  COBRA, combined bisulfite and restriction analyses , HNPCC, hereditary nonpolyposis colorectal cancer , MLPA, multiplex ligation-dependent probe assay , MSI, microsatellite instability , PBL, peripheral blood lymphocyte , PCR, polymerase chain reaction , RT, reverse transcription , SNP, single nucleotide polymorphism

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the National Health and Medical Research Council of Australia and the New South Wales State Cancer Council.

PII: S0016-5085(05)01787-7

doi:10.1053/j.gastro.2005.09.003

Gastroenterology
Volume 129, Issue 5 , Pages 1392-1399, November 2005